PMS-CLARITHROMYCIN 500 MG — DIN 02247574
CLARITHROMYCIN : 500 MG · PHARMASCIENCE INC · TABLET · wholesale supply in Canada
Health Canada status: DORMANT
What is PMS-CLARITHROMYCIN?
PMS-CLARITHROMYCIN 500 MG contains CLARITHROMYCIN : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02247574, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 31-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Clarithromycin cost around the world?
Clarithromycin is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 40 | 45 | SAR███.██ |
| South Africa | single exit price | 33 | 39 | ZAR███.██ |
| Greece | producer price (ex-factory) | 30 | 30 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 8 | 29 | CZK███.██ |
| United States | acquisition | 4 | 25 | USD███.██ |
| Bahrain | retail (max) | 14 | 24 | BHD███.██ |
| Romania | max producer price | 16 | 23 | RON███.██ |
| United Arab Emirates | public | 18 | 21 | AED███.██ |
| Austria | KVP (Kassenverkaufspreis) | 15 | 21 | EUR███.██ |
| Luxembourg | reimbursement | 10 | 10 | EUR███.██ |
| United Kingdom | hospital | 6 | 6 | GBP███.██ |
| Australia | ex-manufacturer | 4 | 5 | AUD███.██ |
278 pack listings across 198 brand entries and 11 price bases, refreshed 10 Sep 2026. Ranges span every Clarithromycin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Clarithromycin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
17 holders have a Canadian DIN containing Clarithromycin, across 45 DINs, of which 21 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BGP PHARMA ULC | 5 | 4 | BIAXIN, BIAXIN BID, BIAXIN XL | Sourceable in Canada |
| APOTEX INC | 3 | 3 | APO-CLARITHROMYCIN, APO-CLARITHROMYCIN XL | Sourceable in Canada |
| SUN PHARMA CANADA INC | 5 | 2 | RAN-CLARITHROMYCIN, TARO-CLARITHROMYCIN, TARO-CLARITHROMYCIN XL | Sourceable in Canada |
| SANIS HEALTH INC | 4 | 2 | CLARITHROMYCIN | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 3 | 2 | SANDOZ CLARITHROMYCIN, SANDOZ CLARITHROMYCIN XL | Sourceable in Canada |
| PRO DOC LIMITEE | 2 | 2 | CLARITHROMYCIN | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 2 | 2 | CLARITHROMYCIN | Sourceable in Canada |
| TARO PHARMACEUTICALS INC | 2 | 2 | TARO-CLARITHROMYCIN | Sourceable in Canada |
| TEVA CANADA LIMITED | 3 | 1 | TEVA-CLARITHROMYCIN, TEVA-CLARITHROMYCIN XL | Sourceable in Canada |
| MANTRA PHARMA INC | 2 | 1 | M-CLARITHROMYCIN | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 3 | 0 | RIVA-CLARITHROMYCIN | No marketed DIN |
| AVANSTRA INC | 2 | 0 | AVA-CLARITHROMYCIN | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 500 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Clarithromycin |
|---|---|
| ATC code | J01FA09 |
| AHFS class | 08:12.12.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02247574 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2247574 |
| Brand name | PMS-CLARITHROMYCIN |
| Generic / active ingredient | CLARITHROMYCIN : 500 MG |
| Market authorization holder | PHARMASCIENCE INC |
| Health Canada schedule | Prescription |
| ATC code | J01FA09 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01FA |
| Current status | DORMANT |
| Status date | 31-Jul-2024 |
| Original market date | 2007-08-10 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
21 of 45 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CLARITHROMYCIN | 500 MG | TABLET | APOTEX INC | MARKETED | 02274752 |
| APO-CLARITHROMYCIN | 250 MG | TABLET | APOTEX INC | MARKETED | 02274744 |
| APO-CLARITHROMYCIN XL | 500 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | 02413345 |
| BIAXIN | 125 MG / 5 ML | GRANULES FOR SUSPENSION | BGP PHARMA ULC | MARKETED | 02146908 |
| BIAXIN | 250 MG / 5 ML | GRANULES FOR SUSPENSION | BGP PHARMA ULC | MARKETED | 02244641 |
| BIAXIN BID | 500 MG | TABLET | BGP PHARMA ULC | MARKETED | 02126710 |
| BIAXIN BID | 250 MG | TABLET | BGP PHARMA ULC | MARKETED | 01984853 |
| CLARITHROMYCIN | 250 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02324482 |
| CLARITHROMYCIN | 500 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02324490 |
| CLARITHROMYCIN | 250 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02442469 |
2 · Same class — other molecules in ATC J01FA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Azithromycin | ACT AZITHROMYCIN · AG-AZITHROMYCIN · APO-AZITHROMYCIN · APO-AZITHROMYCIN Z · +29 more | 84 | 23 | Yes |
| Clarithromycin | APO-CLARITHROMYCIN · APO-CLARITHROMYCIN XL · AVA-CLARITHROMYCIN · BIAXIN · +16 more | 45 | 21 | Yes |
| Erythromycin | ALTI-ERYTHROMYCIN TAB 250MG USP · EES 600 TABLETS 600MG · EES-200 · EES-200 CHEWABLE TBS (ERYPED) · +36 more | 47 | 2 | Yes |
| Spiramycin | ROVAMYCINE 250 CAPSULE 750000 UNIT · ROVAMYCINE 500 CAPSULE 1500000 UNIT | 2 | 0 | Not in Canada |
| Telithromycin | KETEK | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01F
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01FF | Clindamycin · Lincomycin | 61 | 24 |
| J01FG | Quinopristin And Dalfopristin | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PMS-CLARITHROMYCIN called?
The same molecule, Clarithromycin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Klacid | Latin | Australia, Bahrain, Czechia |
| FROMILID | Latin | Czechia |
| CLARIDAR | Latin | Bahrain, Saudi Arabia |
| CLARITHROMYCIN TEVA | Latin | Czechia |
| KLACID SR | Latin | Czechia |
| CLARITHROMYCIN OLIKLA | Latin | Czechia |
| CLARITT | Latin | Bahrain |
| CLARITT XL | Latin | Bahrain |
| Claritt® XL | Latin | United Arab Emirates |
| CLARIVA | Latin | Bahrain |
| FROMILID UNO | Latin | Czechia |
| KLACID-XL | Latin | Bahrain |
| SPECTROMAX | Latin | Bahrain |
| CLAREX | Latin | Bahrain |
| Claribax | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Clarithromycin called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Clarithromycin, published to help those searches reach this page.
| Language | Clarithromycin |
|---|---|
| Chinese (Simplified) 简体中文 | 克拉霉素 |
| Russian Русский | кларитромицин |
| French Français | clarithromycine |
| German Deutsch | Clarithromycin |
| Hindi हिन्दी | क्लैरिथ्रोमाइसिन |
| Japanese 日本語 | クラリスロマイシン |
| Korean 한국어 | 클라리스로마이신 |
| Vietnamese Tiếng Việt | clarithromycin |
| Greek Ελληνικά | κλαριθρομυκίνη |
| Polish Polski | klarytromycyna |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.